Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trialsJason Q Core, Peiying Hua, Ebenezer Daniel, Juan E Grunwald, Glenn Jaffe, Maureen G Maguire, Gui-shuang Ying, David F. Williams, Sara Beardsley, Steven Bennett, Herbert Cantrill, Carmen Chan-Tram, Holly Cheshier, John Davies, Sundeep Dev
See the full list of authors15 April 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Robert Petrarca, Katherine Alyson Muldrew, Tunde Peto, Usha Chakravarthy, Luke Membrey, Richard Haynes, Mark Costen, David H W Steel, Riti Desai, Fiona Bishop
See the full list of authors25 February 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies
25 January 2022
Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendationsManuel Vargas-Peirano, Catalina Verdejo, Laura Vergara-Merino, Cristóbal Loézar, Martin Hoehmann, Javier Pérez-Bracchiglione
14 December 2021
Ten-year survival trends of neovascular age-related macular degeneration at first presentationCristina Arpa, Hagar Khalid, Shruti Chandra, Siegfried Wagner, Katrin Fasler, Livia Faes, Pakinee Pooprasert, Reena Chopra, Gabriella Moraes, Konstantinos Balaskas, Pearse A Keane, Sobha Sivaprasad, Dun Jack Fu
25 November 2021
Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survivalWei Zhang, Alfrun Schönberg, Matthias Hamdorf, Tihomir Georgiev, Claus Cursiefen, Felix Bock
22 November 2021
OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based studySimon KH Szeto, Vivian W. K. Hui, Fang Yao Tang, Dawei Yang, Zi han Sun, Shaheeda Mohamed, Carmen K M Chan, Timothy Y Y Lai, Carol Cheung
8 November 2021
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidenceVincent Daien, Robert P Finger, James S Talks, Paul Mitchell, Tien Y Wong, Taiji Sakamoto, Bora M Eldem, Jean-François Korobelnik
21 October 2021
Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapyMengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A Datoo O'Keefe, Charles C Wykoff, David Sarraf, A’sha Brown, Shaun Ian Retief Lampen, Brenda Zhou, Alexander M Rusakevich, SriniVas Sadda
24 September 2021
Predicting the immediate impact of national lockdown on neovascular age-related macular degeneration and associated visual morbidity: an INSIGHT Health Data Research Hub for Eye Health reportSusan P Mollan, Dun Jack Fu, Ching-Yi Chuo, Jacqueline G Gannon, Wen Hwa Lee, J Jill Hopkins, Cian Hughes, Alastair K Denniston, Pearse A Keane, Ronald Cantrell
13 September 2021
